Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 27 June 2018 | By Zachary Brennan
China’s State Drug Administration (SDA, formerly known as the CFDA) announced yesterday that for the first time since 2014, a major overhaul of its medical device regulations has taken root. “It is timely in that U.S. tariffs are anticipated to be levied at 25% duty on many of the medical devices shipped from China to the U.S.,” consultants from China Med Device wrote. China Med Device CEO Grace Fu explained to Focus that this is a draft document and interested persons can submit feedback by 24 July. The final version should be coming before the year’s end, she said. According to the device consultancy, 12 articles were newly added to the regulations, two were deleted and 39 modified. Among the major changes include allowing the registration holder to be independent of the manufacturer and relaxing the requirements on accepting overseas clinical trial data. Certain devices will also be able to win conditional approval to expedite their entry to the market. In addition, class II domestic device approvals have been moved from the provincial regulators to the national one. And according to Chinese consultants from Med Device, provincial and local regulators “will establish career inspectors like the regional FDA inspectors in the U.S.” Fu added that this is a "huge" change as CFDA did not have career inspectors prior to the drafting of these new regulations. She also said there will be more postmarket studies conducted in China and more contract manufacturers. Text (in Chinese) Updated with comment from Grace Fu.
Regulatory Focus newsletters
All the biggest regulatory news and happenings.